Stuglik Brian M
SEC Form 4 insider trading activity
Stuglik Brian M has filed 4 SEC Form 4 filings (5 transaction rows) across 2 companies, including PBYI, VSTM, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jun 15, 2026.
On the most recent filing, Stuglik Brian M is listed as Director at PUMA BIOTECHNOLOGY, INC. Inside the rolling window, Stuglik Brian M reported no open-market purchases and 2 open-market sales totaling $64K in PBYI and VSTM. The largest disclosed transaction in the window is a sale of 8,100 PBYI shares on Jun 12, 2026, worth $58K.
Companies traded
Other insiders at PBYI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$64K
reported sales (SEC code S)
Companies
2
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 16, 2025 | VSTM | Sale | $6K |
Frequently asked questions
How many SEC Form 4 filings has Stuglik Brian M made?
Stuglik Brian M has filed 4 SEC Form 4 filings (5 transaction rows) across 2 companies, including PBYI, VSTM since 2025.
Which companies does Stuglik Brian M trade?
Stuglik Brian M has filed SEC Form 4 disclosures for 2 companies, including PBYI, VSTM.
When was Stuglik Brian M's most recent SEC Form 4 filing?
Stuglik Brian M's most recent SEC Form 4 filing on Tracefour is dated Jun 15, 2026.
What is Stuglik Brian M's total buy and sell value in the current window?
Inside the rolling retention window, Stuglik Brian M bought $0 and sold $64K based on SEC Form 4 filings.
What was Stuglik Brian M's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 8,100 PBYI shares on 2026-06-12, worth $58K, per SEC Form 4 filings.